Published in Hepatitis Weekly, September 22nd, 1997
Researcher Yun-Fan Liaw and colleagues suggested that interferon therapy could be harmful when it facilitates clearance of one virus, thereby removing its suppressive effect on the emergence of the other ("Response of Patients with Dual Hepatitis B Virus and C Virus Infection to Interferon Therapy," Journal of Interferon and Cytokine Research, September 1997;17:449-452).
Interferon alpha (IFN-(alpha)) is currently the only antiviral agent approved for the treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly